UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Inject Kerala Ltd reported a sharp drop in Q2 FY26 revenue at ₹157.63 lakhs, down from ₹861.09 lakhs in the same quarter last year — an approximate 82% year-on-year decline. Total income for the quarter stood at ₹163.38 lakhs, with profit after tax (PAT) at just ₹6.75 lakhs versus ₹61.01 lakhs in Q2 FY25. For the half-year (H1 FY26), revenue from operations fell to ₹399.75 lakhs from ₹1,165.63 lakhs, and PAT dropped to ₹14.10 lakhs from ₹73.24 lakhs. The company continues to carry negative reserves of ₹(448.13) lakhs, though total equity remains positive at ₹1,015.35 lakhs. Operating cash flow for the half-year was positive at ₹14.36 lakhs, and cash balance rose to ₹22.74 lakhs. The statutory auditor (M/s. S. Mandawat & Co.) issued a clean limited review report with no qualifications.
The dramatic year-on-year revenue and profit decline signals serious business contraction, which is a major negative for shareholders. While the auditor raised no concerns and the company is still profitable and cash-flow positive, investors should monitor whether the steep drop is temporary or indicative of a structural issue.